Fig. 2From: Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes centerChanges in glycemic control (a) and body weight (b) over time in analyzed T2DM patients from baseline up to 18 months of follow-up periodBack to article page